|
24
|
116
|
9rgkA |
Human transthyretin i107v mutant |
|
0
|
113
|
9px9A |
Attr v122i cardiac amyloid fibrils |
|
0
|
113
|
9px6A |
Attr cardiac amyloid fibrils apex1 |
|
1
|
113
|
9px7A |
Attr cardiac amyloid fibrils apex2 |
|
27
|
116
|
9wpbA |
Crystal structure of human transthyretin (ttr) with pryazole-based stabilizer |
|
0
|
113
|
9zldA |
Cryo-em structure of hepatic amyloid fibril from a variant attrv122delta, single filament morphology |
|
23
|
116
|
9zbvA |
Human ttr-c10a at ph 7.4 |
|
2
|
113
|
9nnnA |
Cryo-em structure of amyloid fibril extracted from the heart of a variant attr d38a amyloidosis patient |
|
1
|
115
|
9hywA |
Cryo-em structure of attrv-f64s amyloid fibril from patient skin tissue. |
|
1
|
114
|
9hx3A |
Amyloid fibril of ttr |
|
25
|
116
|
9h5xA |
Crystal structure of human v122i transthyretin in complex with (3,4-dihydroxy-5-nitrophenyl)-(3-fluoro-5-hydroxyphenyl)methanone compound |
|
27
|
116
|
9h5yA |
Crystal structure of human v30m transthyretin in complex with (3,4-dihydroxy-5-nitrophenyl)-(3-fluoro-5-hydroxyphenyl)methanone compound |
|
0
|
112
|
9bdmA |
Cryo-em structure of cardiac amyloid fibril from a variant attrv122delta, single filament morphology |
|
0
|
112
|
9bdrA |
Cryo-em structure of cardiac amyloid fibril from a variant attrv122delta, double filament morphology 1 |
|
21
|
117
|
8ve1A |
Human transthyretin covalently modified with a2-derived stilbene in the canonical conformation |
|
13
|
117
|
8ve6A |
(biarylamine-ft2-wt)1(c10a)3-human transthyretin in the frayed conformation |
|
19
|
117
|
8ve5A |
(biarylamine-ft2-wt)1(c10a)3-human transthyretin in the compressed conformation |
|
18
|
117
|
8ve4A |
Unliganded human transthyretin in the frayed conformation |
|
16
|
117
|
8ve2A |
Unliganded human transthyretin in the canonical conformation |
|
15
|
117
|
8ve3A |
Unliganded human transthyretin in the compressed conformation |
|
24
|
115
|
8yqdA |
Crystal structure of human transthyretin variant a97s in complex with tafamidis |
|
28
|
115
|
8u52A |
Co-crystal structure of human transthyretin conjugated to the stilbene substructure derived from reaction with the fluorogenic covalent kinetic stabilizer a2 |
|
26
|
116
|
9fhaA |
Human transthyretin (ttr) in complex with (e)-2-((((2-(trifluoromethyl)benzyl)oxy)imino)methyl)benzoic acid |
|
26
|
117
|
9ff6A |
Human transthyretin (ttr) in complex with (e)-4-((((2-methoxybenzyl)oxy)imino)methyl)benzoic acid (lic157) |
|
23
|
117
|
9ff8A |
Human transthyretin (ttr) in complex with (e)-2-((((2-chlorobenzyl)oxy)imino)methyl)benzoic acid (lic166) |
|
29
|
115
|
9rspA |
Cryogenic crystal structure of the perdeuterated ttr mutant v30m at ph5. |
|
27
|
115
|
9rtoA |
Room temperature crystal structure of the perdeuterated ttr mutant v30m at ph5. |
|
29
|
115
|
9rsrA |
Cryogenic crystal structure of the ttr mutant v30m at ph5. |
|
0
|
113
|
9d23A |
Cryo-em structure of amyloid fibril extracted from heart of a variant attr t60a amyloidosis patient 2 |
|
0
|
114
|
9d2gA |
Cryo-em structure of amyloid fibril extracted from liver of a variant attr t60a amyloidosis patient 3 |
|
0
|
113
|
9d21A |
Cryo-em structure of amyloid fibril extracted from heart of a variant attr t60a amyloidosis patient 1 |
|
1
|
114
|
9d24A |
Cryo-em structure of amyloid fibril extracted from thyroid of a variant attr t60a amyloidosis patient 3 |
|
2
|
112
|
9d27A |
Cryo-em structure of amyloid fibril extracted from kidney of a variant attr t60a amyloidosis patient 3 |
|
26
|
115
|
8wguA |
Crystal structure of v30m-ttr in complex with compound 20 |
|
28
|
115
|
8wgtA |
Crystal structure of v30m-ttr in complex with compound 7 |
|
25
|
115
|
8wgsA |
Crystal structure of v30m-ttr in complex with compound 4 |
|
26
|
116
|
8pmaA |
Crystal structure of human v30m transthyretin in complex with pitb (pharmacokinetically improved ttr binder) |
|
26
|
116
|
8pm9A |
Crystal structure of human wild type transthyretin in complex with pitb (pharmacokinetically improved ttr binder) |
|
27
|
116
|
8pm8A |
V30m transthyretin structure in complex with tolcalpone |
|
28
|
116
|
8pmoA |
Crystal structure of human v122i transthyretin in complex with pitb (pharmacokinetically improved ttr binder) |
|
28
|
115
|
8jokA |
Crystal structure of v30l mutated human transthyretin |
|
27
|
115
|
8jqwA |
Crystal structure of v30i mutated human transthyretin |
|
28
|
115
|
8jnuA |
Crystal structure of v30g mutated human transthyretin |
|
26
|
116
|
8w1nA |
Structure of transthyretin pathogenic mutation a120s |
|
23
|
116
|
8w2wA |
Structure of transthyretin synthetic mutation a120l |
|
0
|
114
|
8gbrA |
Cardiac amyloid fibrils extracted from a wild-type attr amyloidosis patient |
|
0
|
113
|
8g9rA |
Cardiac amyloid fibrils extracted from a wild-type attr amyloidosis patient |
|
19
|
117
|
8ve0A |
Human transthyretin covalently modified with a2-derived stilbene in the compressed conformation |
|
26
|
115
|
8i00A |
Crystal structure of a97s transthyretin |
|
26
|
116
|
8c86A |
Crystal structure of human transthyretin in complex with 3-o-methyltolcapone analogue 2 |
